Head-to-head · WeighScore
Elara MD vs Rixa Health
The verdict
Rixa Health takes it — 60.5/100 to 53.5/100.
Rixa Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rixa Health is a direct-to-consumer functional-medicine telehealth practice prescribing compounded and oral semaglutide and tirzepatide (plus other peptides) for weight loss via partner US pharmacies.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Elara MD | Rixa Health |
|---|---|---|
| WeighScore | 53.5/100 | 60.5/100 |
| Grade | C | C |
| Scorecard rank | #466 | #320 |
| Semaglutide | $249/mo (0.2 mg dose, compounded) | Not disclosed |
| Tirzepatide | $349/mo (2.0 mg dose, compounded) | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #466 · C
Strengths
- Dose-banded monthly pricing published on-site ($249–$649/mo across tiers)
- Both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) option, plus microdosing
- Medication included in the monthly price with free fast shipping when prescribed
- Broad reach claimed (over 40 states)
Where it loses points
- Molecules not named on-site (only 'Personalized GLP-1') — compounded status is inferred
- No FDA compounded-medication disclaimer published
- No named compounding pharmacy partner — prescriptions are patient-directed
- LegitScript certification, medical director, and full state list not disclosed
- Pricier than several compounded competitors
Graded #320 · C
Strengths
- Functional-medicine, root-cause clinical approach
- Compounded and oral semaglutide plus tirzepatide offered
- Board-certified DO and FNP providers with years of experience
- Medication bundled with visits into a single price
- No charge until after approval
Where it loses points
- No public monthly pricing; quoted only during consultation
- Relies on compounded GLP-1, which is not FDA-approved as a finished drug
- A handful of states still listed as coming soon
- Branded GLP-1 medications are not the primary offering
- Requires ongoing monthly follow-up commitment
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.